Ninety One North America’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-5,944
Closed -$470K 108
2020
Q3
$470K Sell
5,944
-48,950
-89% -$3.83M 0.05% 98
2020
Q2
$4.05M Hold
54,894
0.42% 51
2020
Q1
$4.03M Buy
54,894
+3,162
+6% +$249K 0.33% 52
2019
Q4
$4.49M Buy
51,732
+3,151
+6% +$259K 0.37% 48
2019
Q3
$3.9M Sell
48,581
-13,187
-21% -$1.06M 0.35% 46
2019
Q2
$4.94M Sell
61,768
-1,103
-2% -$84.5K 0.43% 46
2019
Q1
$4.99M Sell
62,871
-2,124
-3% -$159K 0.47% 48
2018
Q4
$4.74M Sell
64,995
-45,202
-41% -$3.19M 0.5% 48
2018
Q3
$7.46M Sell
110,197
-16,758
-13% -$1.07M 0.64% 45
2018
Q2
$7.35M Buy
+126,955
New +$7.16M 0.53% 54

Other funds holding MRK

Ninety One North America's MRK Position: Q4 2020 in Review

Ninety One North America sold out of Merck (MRK) in Q4 2020, closing a stake of 5,944 shares — an estimated $470K sold.

Ninety One North America first reported a position in MRK in Q2 2018 and held it in 10 quarters. The position peaked at $7.46M in Q3 2018. 2,708 funds tracked by Wall St. Rank hold MRK as of Q4 2020.

  • Ninety One North America reported no remaining Merck position as of Q4 2020 after selling out during the quarter.
  • Ninety One North America sold 5,944 Merck shares in Q4 2020, an estimated $470K.
  • Ninety One North America first reported a position in Merck in Q2 2018 and held it in 10 quarters.
  • Ninety One North America's Merck position peaked at $7.46M in Q3 2018.
  • 2,708 funds tracked by Wall St. Rank held Merck as of Q4 2020.

Based on Ninety One North America's 13F filing for Q4 2020, filed 5 Feb 2021.